Discovery of novel halogenated 8-hydroxyquinoline-based anti-MRSA agents: In vitro and QSAR studies

Drug Dev Res. 2020 Feb;81(1):127-135. doi: 10.1002/ddr.21611. Epub 2019 Oct 16.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infection has been considered to be one of global health problems due to limited classes of effective antimicrobial drugs. Herein, 8-hydroxyquinoline (8HQ) and its derivatives (1-7) were investigated for their anti-MRSA and antioxidant activities. Cloxyquin (2), a halogenated 8HQ, exerted the highest antimicrobial activity (MIC50 ≤ 5.57 μM) with high safety index, whereas an amino-derivative 7 showed the strongest antioxidant activity. Additionally, quantitative structure-activity relationship (QSAR) study demonstrated that mass, polarizability, topological charge, and van der Waals volume are essential properties governing the anti-MRSA activity. Taken together, cloxyquin was highlighted as a promising compound for further development as a novel anti-MRSA agent. QSAR findings would also benefit for further rational design of novel 8HQ-based compounds to combat the MRSA resistance.

Keywords: 8-hydroxyquinoline; QSAR; antimicrobial activity; antioxidant activity; cloxyquin; methicillin-resistant Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chloroquinolinols / chemical synthesis*
  • Chloroquinolinols / chemistry
  • Chloroquinolinols / pharmacology
  • Drug Design
  • Halogens / chemistry
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Oxyquinoline / chemistry*
  • Quantitative Structure-Activity Relationship

Substances

  • Chloroquinolinols
  • Halogens
  • Oxyquinoline
  • cloxyquin